Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marcus D Köller"'
Autor:
Michaela Ernst, Josef S Smolen, Marcus D Köller, Alexa Binder, Tanja Stamm, Helga Radner, Daniel Aletaha, Christoph Böhler
Publikováno v:
Rheumatology. 51:2051-2057
Objective. To examine the correlation between disease activity of RA and the risk of falling.Methods. Seventy-eight patients were tested. Disease activity was measured with acute-phase reactants, autoantibodies, swollen and tender joint count (SJC28,
Publikováno v:
Rheumatology. 48:1575-1580
Objective. To compare the efficacy of MTX and MTXþTNF inhibitors (TNFis) in elderly patients with RA with that in patients of younger age. Methods. Data from two large, randomized, controlled, double-blind trials in patients with early RA using adal
Autor:
Marcus D Köller
Publikováno v:
Wiener Medizinische Wochenschrift. 156:53-60
Rheumatoid arthritis (RA) is the most common inflammatory joint disease in adults leading to pain and disability. New drugs, called biologicals, have opened up new possibilities in the treatment of RA.Targeting pro-inflammatory cytokines such as tumo
Autor:
Peter Pietschmann, Johannes Grisar, B Zwölfer, Marcus D Köller, Martin Aringer, L Wagner, D Eselböck, B Zierhut, Georg Stummvoll, Josef S. Smolen, C W Steiner
Publikováno v:
Annals of the Rheumatic Diseases. 63:1632-1637
To test whether the active metabolite of leflunomide (LEF-M), in addition to blocking the proliferation of activated lymphocytes by inhibiting dihydro-orotate dehydrogenase (DHODH), influences the transendothelial migration (TEM) of peripheral blood
Publikováno v:
Annals of the Rheumatic Diseases. 75:480.2-481
Background Rheumatoid arthritis is an inflammatory musculoskeletal disease, which presents mainly by joint swelling and pain, but also with a variety of other symptoms. Anemia has already been detected as additional marker for disease activity but th
Autor:
Marcus D Köller, Christine Marosi
Publikováno v:
ESMO Open
Despite the sustained trend of decreasing overall cancer incidence, the number of elderly patients with cancer will considerably increase in the coming years, as the incidence of cancer is elevated 11-fold after the age of 65 years compared to adults
Autor:
Marcus D Köller
Publikováno v:
Core Evidence
Marcus D. KöllerMedical University of Vienna, Vienna, AustriaIntroduction: Rheumatoid arthritis (RA) is the most common inflammatory joint disease in adults with a prevalence of 0.5–1%. The development of targeted therapies, especially anti-TNF (t
Publikováno v:
International immunology. 16(11)
Systemic lupus erythematosus (SLE) represents an autoimmune disease for which alterations of T cells, B cells as well as various antigen-presenting cell (APC) populations have been described. In order to better define APC-associated deficiencies, we
Autor:
S Kapiotis, D Wachauer, Marcus D Köller, H Hiesberger, W Füreder, U Firbas, Stefan Winkler, Georg Schett, Josef S. Smolen
Publikováno v:
Rheumatology (Oxford, England). 40(4)
Objective. This study was performed to assess erythropoietin levels and anti-erythropoietin antibodies in patients with systemic lupus erythematosus (SLE). Methods. The sera of 100 patients with SLE were investigated for serum erythropoietin levels a
Autor:
Silvia Hayer, Jean-Pierre David, Josef S Smolen, Kurt Redlich, Günter Steiner, Romeo Ricci, Georg Schett, Erwin F. Wagner, Marcus D Köller
Publikováno v:
Arthritis Research & Therapy. 7:R166
Tumour necrosis factor (TNF) signalling molecules are considered as promising therapeutic targets of antirheumatic therapy. Among them, mitogen-activated protein kinases are thought to be of central importance. Herein, we investigate the role in vivo